MA-23-0034
MA-23-0033
MA-23-0032
LA-23-0019
LA-23-0017
CMS is approving this time-limited state plan amendment to allow the state to implement temporary policies while returning to normal operations after the COVID-19 national emergency. The purpose of this amendment is to amend the provisions governing Targeted Case Management in order to extend the suspension of face-to-face requirements as approved in disaster relief SPA 20-0006, through November 11, 2023.
OR-23-0008
This SPA has been submitted to reflect reimbursement for Clotting Factor from Specialty Pharmacies.